ABVC BioPharma (ABVC)

• Market cap: $31M
• 1 day: -5.43%
• 5 days: -8.27%
• 1 month: -19.21%
• 3 months: -48.09%
• 6 months: -57.49%
• Year to date: -44.29%
• 1 year: 83.46%
• 5 years: -95.92%
• 10 years: -95.92%
• Sector: Healthcare
• Industry: Biotechnology

About: ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Employees: 19